IN2014DN08198A - - Google Patents

Info

Publication number
IN2014DN08198A
IN2014DN08198A IN8198DEN2014A IN2014DN08198A IN 2014DN08198 A IN2014DN08198 A IN 2014DN08198A IN 8198DEN2014 A IN8198DEN2014 A IN 8198DEN2014A IN 2014DN08198 A IN2014DN08198 A IN 2014DN08198A
Authority
IN
India
Prior art keywords
crystal form
compounds
parameters
androsta
triol
Prior art date
Application number
Other languages
English (en)
Inventor
Suizhen Lin
Jingxia Zhang
Xinhua Li
Original Assignee
Guangzhou Celprotek Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46557937&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2014DN08198(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Guangzhou Celprotek Pharmaceutical Co Ltd filed Critical Guangzhou Celprotek Pharmaceutical Co Ltd
Publication of IN2014DN08198A publication Critical patent/IN2014DN08198A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0007Androstane derivatives not substituted in position 17
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
IN8198DEN2014 2012-03-08 2012-04-11 IN2014DN08198A (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201210060611.6A CN102617685B (zh) 2012-03-08 2012-03-08 雄甾-3β,5α,6β-三醇的晶型化合物及其制备方法
PCT/CN2012/073854 WO2013131305A1 (zh) 2012-03-08 2012-04-11 雄甾-3β,5α,6β-三醇的晶型化合物及其制备方法

Publications (1)

Publication Number Publication Date
IN2014DN08198A true IN2014DN08198A (enExample) 2015-05-01

Family

ID=46557937

Family Applications (1)

Application Number Title Priority Date Filing Date
IN8198DEN2014 IN2014DN08198A (enExample) 2012-03-08 2012-04-11

Country Status (13)

Country Link
US (3) US9688716B2 (enExample)
EP (2) EP3112374A1 (enExample)
JP (1) JP2015511587A (enExample)
KR (1) KR20150002653A (enExample)
CN (4) CN103626817B (enExample)
AU (1) AU2012372640B2 (enExample)
CA (2) CA2866398C (enExample)
IL (1) IL234492A (enExample)
IN (1) IN2014DN08198A (enExample)
RU (1) RU2608894C2 (enExample)
SG (1) SG11201405376TA (enExample)
TW (1) TW201336861A (enExample)
WO (1) WO2013131305A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9815258B2 (en) 2012-05-07 2017-11-14 The Procter & Gamble Company Flexible containers
CN109985048B (zh) * 2017-12-29 2021-06-29 广州市赛普特医药科技股份有限公司 2β,3α,5α-三羟基雄甾-6-酮用于炎症反应的治疗
US11532903B2 (en) * 2021-04-01 2022-12-20 Ideal Industries, Inc. Universal electrical connector

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2191576A (en) * 1936-11-21 1940-02-27 Soc Of Chemical Ind 3,5,6-trihydroxy androstane and pregnane compounds
US2191578A (en) 1939-07-24 1940-02-27 Crosley Corp Ice-cream tray
ATE15206T1 (de) * 1981-09-21 1985-09-15 Schering Ag 3-beta,7-beta,15-alpha-trihydroxy-5-androsten-1 - one, ihre 3,15-trimethylessigsaeure-ester und ihre herstellung.
US6046185A (en) * 1996-07-11 2000-04-04 Inflazyme Pharmaceuticals Ltd. 6,7-oxygenated steroids and uses related thereto
CN101884638B (zh) * 2010-07-09 2011-11-09 中山大学 5α-雄甾(烷)-3β,5,6β-三醇在制备神经元保护药物中的应用
CN101961311B (zh) * 2010-09-21 2012-11-21 中山大学 一种5α-雄甾(烷)-3β,5,6β-三醇注射剂及其制备方法
CN102180928B (zh) * 2011-03-15 2013-01-16 广州市赛普特医药科技有限公司 3β,5α,6β-三羟基甾体化合物及其合成方法和应用

Also Published As

Publication number Publication date
CN103626819A (zh) 2014-03-12
US20170305957A1 (en) 2017-10-26
US9688716B2 (en) 2017-06-27
CA2866398A1 (en) 2013-09-12
KR20150002653A (ko) 2015-01-07
CN102617685A (zh) 2012-08-01
IL234492A (en) 2017-02-28
CN103626818A (zh) 2014-03-12
CN103626817A (zh) 2014-03-12
CN102617685B (zh) 2014-01-22
US20170305958A1 (en) 2017-10-26
CA2909998A1 (en) 2013-09-12
CN103626818B (zh) 2016-03-30
RU2014136891A (ru) 2016-05-10
WO2013131305A1 (zh) 2013-09-12
US9944673B2 (en) 2018-04-17
EP3112374A1 (en) 2017-01-04
CA2866398C (en) 2016-06-28
SG11201405376TA (en) 2014-11-27
EP2889303A1 (en) 2015-07-01
US20150045566A1 (en) 2015-02-12
US9944672B2 (en) 2018-04-17
TW201336861A (zh) 2013-09-16
JP2015511587A (ja) 2015-04-20
AU2012372640A1 (en) 2014-09-25
RU2608894C2 (ru) 2017-01-26
EP2889303A4 (en) 2016-02-17
AU2012372640B2 (en) 2015-07-09
CN103626817B (zh) 2016-01-20
CN103626819B (zh) 2016-01-20

Similar Documents

Publication Publication Date Title
EP3028994A4 (en) Silicon carbide powder and method for producing silicon carbide single crystal
ZA201405323B (en) New pyrrole compounds ,a process for their preparation and pharmaceutical compositions containing them
ZA201405418B (en) New phosphate compounds, a process for their preparation and pharmaceutical compositions containing them
ZA201600415B (en) Novel derivatives of indole and pyrrole, method for the production thereof and pharmaceutical compositions containing same
WO2014141292A3 (en) Endoxifen citrate polymorph and process for preparing the same
EP3049185A4 (en) Process for the recovery of components forming a metal-organic framework material
AU2014224456A8 (en) Novel abexinostate salt, associated crystalline form, preparation method thereof and the pharmaceutical compositions containing same
EP2931043A4 (en) PROCESS FOR PREPARING 4-AMINO-5-FLUORO-3-CHLOR-6- (SUBSTITUTED) PICOLINATES
EP3042904A4 (en) Method for preparing improved intermediate for producing high-purity pemetrexed and method for producing high-purity pemetrexed using intermediate
MX2018009847A (es) Metodo para preparar derivado de polietilenglicol-dialdehido.
MX2017015505A (es) Composicion de preparacion solida que contiene pranlukast con biodisponibilidad mejorada y metodo para preparar la misma.
IN2014DN08198A (enExample)
EP2767617A4 (en) HIGH-PURITY MANGANE AND MANUFACTURING METHOD THEREFOR
EP2892886B8 (en) Process for the production of furan derivatives
EP2931047A4 (en) PROCESS FOR PREPARING 4-AMINO-5-FLUORO-3-CHLOR-6- (SUBSTITUTED) PICOLINATES
EP3248938A4 (en) Production method for carbon material using crucible
IL245260A0 (en) Non-aqueous crystalline form of cabazitaxel, process for its preparation and pharmaceutical compositions thereof
IL242897A0 (en) A process for the preparation of pyridylpyrazole compounds and their derivatives from pyridylhydrazine
ZA201406287B (en) Process for preparing diketonato-rhodium(i)-carbonyl complexes
WO2013121439A3 (en) Garenoxacin mesylate, process for preparation thereof, and crystalline form thereof.
SG11201406708XA (en) Itq-49 material, method for the production thereof and use of same
IN2013MU02528A (enExample)
ZA201409488B (en) Method for preparing ual2 powder and uai2 powder prepared according to the same
IN2013MU03508A (enExample)
IN2014MN01941A (enExample)